In metastatic colorectal cancer patients treated with cetuximab or bevacizumab plus chemotherapy, CD15 expression in cancer cells was associated with worse progression-free survival and overall survival [19]. The gene discussed is FUT4; the disease is metastatic colorectal cancer.